Natasha N Frederick1, Lisa Kenney2, Lynda Vrooman3,2, Christopher J Recklitis2. 1. Dana-Farber/Boston Children's Blood Disorders Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. natasha_frederick@dfci.harvard.edu. 2. Perini Family Survivors' Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. 3. Dana-Farber/Boston Children's Blood Disorders Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.
Abstract
PURPOSE: Studies of fatigue in childhood cancer survivors (CCS) are inconclusive, with some reporting increased fatigue prevalence in this population while others do not. Given the potentially significant consequences of unmanaged fatigue, we sought to estimate the prevalence of fatigue and to identify factors associated with fatigue in a population of non-CNS CCS ranging from adolescence to middle adulthood using a single fatigue measurement tool. METHODS: Two hundred sixty-eight CCS ages 12-49 years followed in a survivorship clinic at a single cancer center completed validated self-report measures of fatigue, depression, and quality of life. Demographic and current health data were collected by study questionnaire and chart review RESULTS: Based on age-adjusted population norms, the prevalence of fatigue was 13.8 %, which is not significantly different compared to results in healthy populations. Fatigue was independently associated with having ≥3 chronic health conditions (OR 4.27, 95 % CI 1.52-11.99). Fatigued participants reported lower overall quality of life scores (OR 0.86, 95 % CI 0.82-0.89) and were more likely to be depressed compared to non-fatigued patients (20.4 vs. 1.4 %, respectively, p < 0.0001). There were 41(78.8 %) survivors with fatigue in our population who did not report significant depression. CONCLUSIONS: CCS did not demonstrate increased fatigue compared to age-matched normative data. Fatigued survivors were more likely to have multiple chronic conditions, depression, and decreased quality of life. Longitudinal study will promote better understanding of the relationship between fatigue and specific chronic conditions, thereby facilitating early identification of those individuals most at risk.
PURPOSE: Studies of fatigue in childhood cancer survivors (CCS) are inconclusive, with some reporting increased fatigue prevalence in this population while others do not. Given the potentially significant consequences of unmanaged fatigue, we sought to estimate the prevalence of fatigue and to identify factors associated with fatigue in a population of non-CNS CCS ranging from adolescence to middle adulthood using a single fatigue measurement tool. METHODS: Two hundred sixty-eight CCS ages 12-49 years followed in a survivorship clinic at a single cancer center completed validated self-report measures of fatigue, depression, and quality of life. Demographic and current health data were collected by study questionnaire and chart review RESULTS: Based on age-adjusted population norms, the prevalence of fatigue was 13.8 %, which is not significantly different compared to results in healthy populations. Fatigue was independently associated with having ≥3 chronic health conditions (OR 4.27, 95 % CI 1.52-11.99). Fatigued participants reported lower overall quality of life scores (OR 0.86, 95 % CI 0.82-0.89) and were more likely to be depressed compared to non-fatigued patients (20.4 vs. 1.4 %, respectively, p < 0.0001). There were 41(78.8 %) survivors with fatigue in our population who did not report significant depression. CONCLUSIONS: CCS did not demonstrate increased fatigue compared to age-matched normative data. Fatigued survivors were more likely to have multiple chronic conditions, depression, and decreased quality of life. Longitudinal study will promote better understanding of the relationship between fatigue and specific chronic conditions, thereby facilitating early identification of those individuals most at risk.
Entities:
Keywords:
Childhood cancer; Fatigue; Late effects; Survivorship
Authors: J Zabora; K BrintzenhofeSzoc; P Jacobsen; B Curbow; S Piantadosi; C Hooker; A Owens; L Derogatis Journal: Psychosomatics Date: 2001 May-Jun Impact factor: 2.386
Authors: Rhonda S Robert; Raheem J Paxton; Shana L Palla; Grace Yang; Martha A Askins; Shaini E Joy; Joann L Ater Journal: Pediatr Blood Cancer Date: 2012-02-02 Impact factor: 3.167
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Lisa B Kenney; Cheryl Medeiros Nancarrow; Julie Najita; Lynda M Vrooman; Monica Rothwell; Christopher Recklitis; Frederick P Li; Lisa Diller Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Sharon L Bober; Eric S Zhou; Bing Chen; Peter E Manley; Lisa B Kenney; Christopher J Recklitis Journal: J Sex Med Date: 2013-05-16 Impact factor: 3.802
Authors: Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison Journal: JAMA Date: 2013-06-12 Impact factor: 56.272
Authors: Christopher J Recklitis; Susan K Parsons; Mei-Chiung Shih; Ann Mertens; Leslie L Robison; Lonnie Zeltzer Journal: Psychol Assess Date: 2006-03
Authors: Adriaan Penson; Iris Walraven; Ewald Bronkhorst; Heleen Maurice-Stam; Martha A Grootenhuis; Margriet Van der Heiden-van der Loo; Wim J E Tissing; Helena J H Van der Pal; Andrica C H De Vries; Dorine Bresters; Cécile Ronckers; Marry M Van den Heuvel; Sebastian J C M M Neggers; Birgitta A B Versluys; Marloes Louwerens; Saskia M F Pluijm; Leontien C M Kremer; Nicole Blijlevens; Eline Van Dulmen-den Broeder; Hans Knoop; Jacqueline Loonen Journal: Cancers (Basel) Date: 2022-06-09 Impact factor: 6.575
Authors: Sylvia van Deuren; Adriaan Penson; Eline van Dulmen-den Broeder; Martha A Grootenhuis; Margriet van der Heiden-van der Loo; Ewald Bronkhorst; Nicole M A Blijlevens; Nina Streefkerk; Jop C Teepen; Wim J E Tissing; Helena J H van der Pal; Marry M van den Heuvel-Eibrink; Birgitta A B Versluys; Dorine Bresters; Flora E van Leeuwen; Cécile M Ronckers; Leontien C M Kremer; Hans Knoop; Jacqueline J Loonen Journal: Cancer Date: 2021-11-01 Impact factor: 6.921
Authors: Salome Christen; Katharina Roser; Renée L Mulder; Anica Ilic; Hanne C Lie; Jacqueline J Loonen; Anneli V Mellblom; Leontien C M Kremer; Melissa M Hudson; Louis S Constine; Roderick Skinner; Katrin Scheinemann; Jordan Gilleland Marchak; Gisela Michel Journal: J Cancer Surviv Date: 2020-08-25 Impact factor: 4.442